Tissue examination to monitor antiangiogenic therapy: A phase I clinical trial with endostatin

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3366-3374

  Mundhenke, Christoph ^a,d   Thomas, James P ^a   Wilding, George ^a   Lee, Fred T ^a   Kelzc, Fred ^a   Chappell, Rick ^a,c   Neider, Rosemary ^a   Sebree, Linda A ^b   Friedl, Andreas ^a,b  

^a UW Carbone Comprehensive Cancer Center   (United States)

^b Department of Pathology and Laboratory Medicine ^*  (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR BIOPSY; ULTRASTRUCTURE; WOUND HEALING;

ANGIOGENESIS INHIBITORS; ANTIGENS, CD31; APOPTOSIS; BIOPSY; BLOOD VESSELS; COLLAGEN; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICROSCOPY, ELECTRON; NEOPLASMS; PEPTIDE FRAGMENTS; SKIN; WOUND HEALING;

EID: 0035187305     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fighting cancer by attacking its blood supply
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
5. Cloning, expression, and in vitro activity of human endostatin
6. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
7. Inhibitory effect of full-length human endostatin on in vitro angiogenesis
8. Endostatin induces endothelial cell apoptosis
9. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
10. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase
11. Antiangiogenesis signals by endostatin
12. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution
13. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and antiangiogenic activity
14. Cell surface glypicans are low-affinity endostatin receptors
15. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding
16. Disruption of the KEX1 gene in Pichia pastoris allows expression of ful-length murine and human endostatin
17. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
18. Tumor angiogenesis: Past, present and the near future
19. A cancer therapy resistant to resistance
20. Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of the graft-vs.-host reaction
21. Evaluation of wound angiogenesis in healthy volunteers: A potential surrogate marker for antiangiogenesis agents
22. Wound angiogenesis as a potential surrogate marker for anti-angiogenesis clinical trials
23. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
24. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
25. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
26. Genes expressed in human tumor endothelium
27. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing
28. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
29. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing
30. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing
31. Requirement of vascular integrin α v β 3 for angiogenesis
32. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
33. Thromhospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
34. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
35. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
36. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms
37. Angiostatin induces and sustains dormancy of human primary tumors in mice
38. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
39. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
40. A Phase I pharmacodynamic and pharmacokinetic study of endostatin